Beware: ghosts of biotech’s past. Welcome to Fierce Biotech’s graveyard, a yearly ritual in which we remember the companies that shuttered operations in 2024. We don’t take these closures ...

AI is finding its way into every corner of biotech and pharmaceutical research, but like other industries, it’s never quite as straightforward to implement as one would like. Converge Bio has ...

Vertex Pharmaceuticals is a large-cap biotech leader that generates impressive revenue and profits. The company has tremendous potential with multiple new products likely on the way. Most biotech ...

With Donald Trump now poised to become U.S. president for the second time in January, biotech and pharmaceutical leaders are preparing for the shift to an administration with a complicated history.

Vivek Ramaswamy, the biotech entrepreneur who has been selected by President-elect Donald Trump to co-lead a new and as yet ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

We recently compiled a list of the 10 Worst Performing Biotech Stocks in 2024. In this article, we are going to take a look at where Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) stands against the ...

The STA web pages use cookies to ensure proper functioning of all page features. By using our website, you agree to the use ...

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has received Health Canada approval of its ...

Apr. 30, 2024 — Researchers have discovered a new mechanism of oil biosynthesis and found a way to genetically engineer a type of test plant to more efficiently ... Apr. 23, 2024 — Researchers ...

Investing in biotechnology stocks has always required a high risk tolerance and the patience to wait years, even decades, for results. Uneven results in recent years, and in the year to date ...